Comorbid anxiety predicts lower odds of MDD improvement in a trial of smartphone-delivered interventions

合并焦虑症预示着在智能手机干预试验中,重度抑郁症改善的几率较低。

阅读:1

Abstract

Comorbid anxiety disorders are common among patients with major depressive disorder (MDD), but their impact on outcomes of digital and smartphone-delivered interventions is not well understood. This study is a secondary analysis of a randomized controlled effectiveness trial (n=638) that assessed three smartphone-delivered interventions: Project EVO (a cognitive training app), iPST (a problem-solving therapy app), and Health Tips (an active control). We applied classical machine learning models (logistic regression, support vector machines, decision trees, random forests, and k-nearest-neighbors) to identify baseline predictors of MDD improvement at 4 weeks after trial enrollment. Our analysis produced a decision tree model indicating that a baseline GAD-7 questionnaire score of 11 or higher, a threshold consistent with at least moderate anxiety, strongly predicts lower odds of MDD improvement in this trial. Our exploratory findings suggest that depressed individuals with comorbid anxiety have reduced odds of substantial improvement in the context of smartphone-delivered interventions, as the association was observed across all three intervention groups. Our work highlights a methodology that can identify interpretable clinical thresholds, which, if validated, could predict symptom trajectories and inform treatment selection and intensity.(3).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。